HLA-DP on Epithelial Cells enables Tissue Damage by NKp44+ NK Cells in Ulcerative Colitis

Martin E. Baumdick,Annika Niehrs,Frauke Degenhardt,Maria Schwerk,Ole Hinrichs,Ana Jordan-Paiz,Benedetta Padoan,Lucy H.M. Wegner,Sebastian Schloer,Britta F. Zecher,Jakob Malsy,Vinita R. Joshi,Christin Illig,Jennifer Schröder-Schwarz,Kimberly J. Möller,Hamburg Intestinal Tissue Study Group,Alaa Akar,Cornelius Flemming,Felix Flomm,Markus Flosbach,Julia Jäger,Niklas Jeromin,Johannes Jung,Mareike Ohms,Konrad Reinshagen,Johann Rische,Adrian Sagebiel,Deborah Sandfort,Fenja Steinert,Christian Tomuschat,Jasmin Wesche,Maureen Martin,Yuko Yuki,Mikki Ozawa,Jürgen Sauter,Alexander H. Schmidt,Daniel Perez,Anastasios D. Giannou,Mary Carrington,Randall S. Davis,Udo Schumacher,Guido Sauter,Samuel Huber,Victor G. Puelles,Nathaniel Melling,Andre Franke,International IBD Genetics Consortium,Shifteh Abedian,Clara Abraham,Jean-Paul Achkar,Tariq Ahmad,Rudi Alberts,Behrooz Alizadeh,Leila Amininejad,Ashwin N. Ananthakrishnan,Vibeke Andersen,Carl A. Anderson,Jane M. Andrews,Vito Annese,Guy Aumais,Leonard Baidoo,Robert N. Baldassano,Peter A. Bampton,Murray Barclay,Jeffrey C. Barrett,Johannes Bethge,Claire Bewshea,Joshua C. Bis,Alain Bitton,BK Thelma,Gabrielle Boucher,Oliver Brain,Stephan Brand,Steven R. Brant,Jae Hee Cheon,Angela Chew,Judy H. Cho,Isabelle Cleynen,Ariella Cohain,Rachel Cooney,Anthony Croft,Mark J. Daly,Mauro D'Amato,Silvio Danese,Naser Ebrahim Daryani,Lisa Wu Datta,Frauke Degenhardt,Goda Denapiene,Lee A. Denson,Kathy L. Devaney,Olivier Dewit,Renata D'Inca,Hazel E. Drummond,Marla Dubinsky,Richard H. Duerr,Cathryn Edwards,David Ellinghaus,Pierre Ellul,Motohiro Esaki,Jonah Essers,Lynnette R. Ferguson,Eleonora A. Festen,Philip Fleshner,Tim Florin,Denis Franchimont,Andre Franke,Yuta Fuyuno,Richard Gearry,Michel Georges,Christian Gieger,Jürgen Glas,Philippe Goyette,Todd Green,Anne M. Griffiths,Stephen L. Guthery,Hakon Hakonarson,Jonas Halfvarson,Katherine Hanigan,Talin Haritunians,Ailsa Hart,Chris Hawkey,Nicholas K. Hayward,Matija Hedl,Paul Henderson,Georgina L. Hold,Myhunghee Hong,Xinli Hu,Hailiang Huang,Jean-Pierre Hugot,Ken Y. Hui,Marcin Imielinski,Omid Jazayeri,Laimas Jonaitis,Luke Jostins,Garima Juyal,Ramesh Chandra Juyal,Rahul Kalla,Tom H. Karlsen,Nicholas A. Kennedy,Mohammed Azam Khan,Won Ho Kim,Takanari Kitazono,Gediminas Kiudelis,Michiaki Kubo,Subra Kugathasan,Limas Kupcinskas,Christopher A. Lamb,Katrina M. de Lange,Anna Latiano,Debby Laukens,Ian C. Lawrance,James C. Lee,Charlie W. Lees,Marcis Leja,Nina Lewis,Johan Van Limbergen,Paolo Lionetti,Jimmy Z. Liu,Edouard Louis,Yang Luo,Gillian Mahy,Masoud Mohammad Malekzadeh,Reza Malekzadeh,John Mansfield,Suzie Marriott,Dunecan Massey,Christopher G. Mathew,Toshiyuki Matsui,Dermot PB. McGovern,Andrea van der Meulen,Vandana Midha,Raquel Milgrom,Samaneh Mirzaei,Mitja Mitrovic,Grant W. Montgomery,Craig Mowat,Christoph Müller,William G. Newman,Aylwin Ng,Siew C. Ng,Sok Meng Evelyn Ng,Susanna Nikolaus,Kaida Ning,Markus Nöthen,Ioannis Oikonomou,David Okou,Timothy R. Orchard,Orazio Palmieri,Miles Parkes,Anne Phillips,Cyriel Y. Ponsioen,Urõs Potocnik,Hossein Poustchi,Natalie J. Prescott,Deborah D. Proctor,Graham Radford-Smith,Jean- Francois Rahier,Miguel Regueiro,Walter Reinisch,Florian Rieder,John D. Rioux,Rebecca Roberts,Gerhard Rogler,Richard K. Russell,Jeremy D. Sanderson,Miquel Sans,Jack Satsangi,Eric E. Schadt,Michael Scharl,John Schembri,Stefan Schreiber,L Philip Schumm,Regan Scott,Mark Seielstad,Tejas Shah,Yashoda Sharma,Mark S. Silverberg,Alison Simmons,Lisa A. Simms,Abhey Singh,Jurgita Skieceviciene,Suzanne van Sommeren,Kyuyoung Song,Ajit Sood,Sarah L. Spain,A. Hillary Steinhart,Joanne M. Stempak,Laura Stronati,Joseph JY. Sung,Stephan R. Targan,Kirstin M. Taylor,Emilie Theatre,Leif Torkvist,Esther A. Torres,Mark Tremelling,Holm H. Uhlig,Junji Umeno,Homayon Vahedi,Eric Vasiliauskas,Anje ter Velde,Nicholas T. Ventham,Severine Vermeire,Hein W. Verspaget,Martine De Vos,Thomas Walters,Kai Wang,Ming-Hsi Wang,Rinse K. Weersma,Zhi Wei,David Whiteman,Cisca Wijmenga,David C. Wilson,Juliane Winkelmann,Sunny H. Wong,Ramnik J. Xavier,Keiko Yamazaki,Suk-Kyun Yang,Byong Duk Ye,Sebastian Zeissig,Bin Zhang,Clarence K. Zhang,Hu Zhang,Wei Zhang,Hongyu Zhao,Zhen Z. Zhao,Marcus Altfeld,Madeleine J. Bunders,Thelma BK
DOI: https://doi.org/10.1053/j.gastro.2023.06.034
IF: 29.4
2023-07-01
Gastroenterology
Abstract:BACKGROUND &amp; AIMS: &lt;AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE"&gt;Ulcerative colitis (UC) is characterized by severe inflammation and destruction of the intestinal epithelium, and associated with risk of single nucleotide polymorphism in HLA class II. Given the recently discovered interactions between subsets of HLA-DP molecules and the activating natural killer (NK) cell receptor NKp44, genetic associations of UC and HLA-DP haplotypes and their functional implications were investigated.&lt;/AbstractText&gt;METHODS: &lt;AbstractText Label="METHODS" NlmCategory="METHODS"&gt;HLA-DP haplotype and UC risk association analyses were performed (UC: n = 13,927; control: n = 26,764). Expression levels of HLA-DP on intestinal epithelial cells (IECs) in individuals with and without UC were quantified. Human intestinal 3-dimensional (3D) organoid co-cultures with human NK cells were used to determine functional consequences of interactions between HLA-DP and NKp44.&lt;/AbstractText&gt;RESULTS: &lt;AbstractText Label="RESULTS" NlmCategory="RESULTS"&gt;These studies identified HLA-DPA1∗01:03-DPB1∗04:01 (HLA-DP401) as a risk haplotype and HLA-DPA1∗01:03-DPB1∗03:01 (HLA-DP301) as a protective haplotype for UC in European populations. HLA-DP expression was significantly higher on IECs of individuals with UC compared with controls. IECs in human intestinal 3D organoids derived from HLA-DP401<sup>pos</sup> individuals showed significantly stronger binding of NKp44 compared with HLA-DP301<sup>pos</sup> IECs. HLA-DP401<sup>pos</sup> IECs in organoids triggered increased degranulation and tumor necrosis factor production by NKp44<sup>+</sup> NK cells in cocultures, resulting in enhanced epithelial cell death compared with HLA-DP301<sup>pos</sup> organoids. Blocking of HLA-DP401-NKp44 interactions (anti-NKp44) abrogated NK cell activity in cocultures.&lt;/AbstractText&gt;CONCLUSIONS: &lt;AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS"&gt;We identified a UC risk HLA-DP haplotype that engages NKp44 and activates NKp44<sup>+</sup> NK cells, mediating damage to intestinal epithelial cells in an HLA-DP haplotype-dependent manner. The molecular interaction between NKp44 and HLA-DP401 in UC can be targeted by therapeutic interventions to reduce NKp44<sup>+</sup> NK cell-mediated destruction of the intestinal epithelium in UC.&lt;/AbstractText&gt;
gastroenterology & hepatology
What problem does this paper attempt to address?